child |
LDLo |
skin |
1500mg/kg (1500mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: CONJUNCTIVE IRRITATION: EYE
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Quarterly Journal of Pharmacy & Pharmacology. Vol. 6, Pg. 714, 1933. |
child |
LDLo |
skin |
4gm/kg/4D (4000mg/kg) |
? |
Muenchener Medicinische Wochenschrift. Vol. 52, Pg. 763, 1905. |
child |
TDLo |
oral |
500mg/kg (500mg/kg) |
GASTROINTESTINAL: NAUSEA OR VOMITING |
Journal of Toxicology, Clinical Toxicology. Vol. 24, Pg. 269, 1986. |
dog |
LDLo |
oral |
1780mg/kg (1780mg/kg) |
BRAIN AND COVERINGS: MENINGEAL CHANGES
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
GASTROINTESTINAL: NAUSEA OR VOMITING |
JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945. |
dog |
LDLo |
parenteral |
1gm/kg (1000mg/kg) |
PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) |
Rassegna di Terapia e Patologia Clinica. Vol. 1, Pg. 472, 1929. |
dog |
LDLo |
subcutaneous |
1gm/kg (1000mg/kg) |
BRAIN AND COVERINGS: MENINGEAL CHANGES
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
GASTROINTESTINAL: NAUSEA OR VOMITING |
JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945. |
guinea pig |
LD50 |
subcutaneous |
1200mg/kg (1200mg/kg) |
BEHAVIORAL: TREMOR
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: NAUSEA OR VOMITING |
U.S. Army, Chemical Corps Medical Division Special Report. Vol. #2, Pg. 1950, |
guinea pig |
LDLo |
oral |
1gm/kg (1000mg/kg) |
GASTROINTESTINAL: NAUSEA OR VOMITING
GASTROINTESTINAL: OTHER CHANGES |
Revista de la Asociacion Medica Argentina. Vol. 46, Pg. 1493, 1932. |
infant |
LDLo |
oral |
934mg/kg (934mg/kg) |
? |
JAMA, Journal of the American Medical Association. Vol. 90, Pg. 382, 1928. |
infant |
LDLo |
skin |
1200mg/kg (1200mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
JAMA, Journal of the American Medical Association. Vol. 129, Pg. 332, 1945. |
infant |
LDLo |
subcutaneous |
1100mg/kg (1100mg/kg) |
BEHAVIORAL: TREMOR
GASTROINTESTINAL: NAUSEA OR VOMITING
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
U.S. Army, Chemical Corps Medical Division Special Report. Vol. #2, Pg. 1950, |
infant |
TDLo |
oral |
800mg/kg/4W-I (800mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: NAUSEA OR VOMITING |
Archives of Disease in Childhood. Vol. 58, Pg. 737, 1983. |
man |
LDLo |
oral |
429mg/kg (429mg/kg) |
CARDIAC: OTHER CHANGES
KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" |
Journal of Toxicology, Clinical Toxicology. Vol. 31, Pg. 345, 1993. |
man |
LDLo |
skin |
2430mg/kg (2430mg/kg) |
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
SKIN AND APPENDAGES (SKIN): PRIMARY IRRITATION: AFTER TOPICAL EXPOSURE |
JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945. |
man |
LDLo |
unreported |
147mg/kg (147mg/kg) |
? |
"Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970. |
man |
TDLo |
unreported |
170mg/kg (170mg/kg) |
BEHAVIORAL: WAKEFULNESS
BEHAVIORAL: ANOREXIA (HUMAN
GASTROINTESTINAL: NAUSEA OR VOMITING |
Rassegna di Terapia e Patologia Clinica. Vol. 1, Pg. 472, 1929. |
mouse |
LD50 |
intravenous |
1240mg/kg (1240mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION |
Journal of Pharmacology and Experimental Therapeutics. Vol. 134, Pg. 117, 1961. |
mouse |
LD50 |
oral |
3450mg/kg (3450mg/kg) |
? |
JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945. |
mouse |
LD50 |
subcutaneous |
1740mg/kg (1740mg/kg) |
? |
JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945. |
mouse |
LDLo |
intraperitoneal |
800mg/kg (800mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: ATAXIA |
"Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley & Sons, Inc., 1964Vol. -, Pg. 693, 1964. |
rabbit |
LDLo |
intravenous |
800mg/kg (800mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: ATAXIA |
"Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley & Sons, Inc., 1964Vol. -, Pg. 693, 1964. |
rabbit |
LDLo |
oral |
4gm/kg (4000mg/kg) |
BEHAVIORAL: TREMOR
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: NAUSEA OR VOMITING |
U.S. Army, Chemical Corps Medical Division Special Report. Vol. #2, Pg. 1950, |
rabbit |
LDLo |
parenteral |
670mg/kg (670mg/kg) |
? |
Rassegna di Terapia e Patologia Clinica. Vol. 1, Pg. 472, 1929. |
rabbit |
LDLo |
subcutaneous |
150mg/kg (150mg/kg) |
? |
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. |
rat |
LCLo |
inhalation |
28mg/m3/4H (28mg/m3) |
? |
"Toxicometric Parameters of Industrial Toxic Chemicals Under Single Exposure," Izmerov, N.F., et al., Moscow, Centre of International Projects, GKNT, 1982Vol. -, Pg. 27, 1982. |
rat |
LD50 |
intravenous |
1330mg/kg (1330mg/kg) |
BEHAVIORAL: TREMOR
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: NAUSEA OR VOMITING |
U.S. Army, Chemical Corps Medical Division Special Report. Vol. #2, Pg. 1950, |
rat |
LD50 |
oral |
2660mg/kg (2660mg/kg) |
? |
JAMA, Journal of the American Medical Association. Vol. 128, Pg. 266, 1945. |
rat |
LD50 |
subcutaneous |
1400mg/kg (1400mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: ATAXIA |
"Boron, Metallo-Boron Compounds and Boranes," Adams, R.M., ed., New York, John Wiley & Sons, Inc., 1964Vol. -, Pg. 693, 1964. |
women |
LDLo |
oral |
200mg/kg (200mg/kg) |
BEHAVIORAL: FLUID INTAKE
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: NAUSEA OR VOMITING |
Lancet. Vol. 2, Pg. 162, 1917. |
women |
TDLo |
oral |
400mg/kg (400mg/kg) |
GASTROINTESTINAL: NAUSEA OR VOMITING
GASTROINTESTINAL: OTHER CHANGES
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 32, Pg. 804, 1990. |